Paragon Biosciences has been the first AI - based diagnostic tool to be approved for use in radiology by the national FDA . The system , called QuantX , was designed in collaboration with Qlarity Imaging and is used to help researchers assess MRIs positive for breast cancer . In a clinical trial , the tool reduced missed breast cancers by 39 % , while improving overall diagnostic performance by 20 % .
Paragon Biosciences has developed the first AI-based diagnostic tool to be approved for use in radiology by the US FDA. The system, called QuantX, was designed in collaboration with Qlarity Imaging and is used to help radiologists assess MRIs looking for breast cancer. In a clinical study, the tool reduced missed breast cancers by 39%, while improving overall diagnostic performance by 20%.